Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
Meaningful efficacy observed i…
Meaningful efficacy observed i…
GUANGZHOU, China, May 29, 2025…
KUALA LUMPUR, Malaysia, May 29…
O-RAN ALLIANCE Global PlugFest…
KITCHENER, ON, May 29, 2025 /P…
SHANGHAI, May 29, 2025 /PRNews…
MCLEAN, Va., May 29, 2025 /PRN…
SHANGHAI, May 29, 2025 /PRNews…
PORT VILA, Vanuatu, May 29, 20…